Tse‐I Lin

1.4k citations

30 papers · 670 indexed · h-index 11

Impact in

Hepatology top 2%
- Hepatitis C virus research
Infectious Diseases top 5%
- HIV/AIDS drug development and treatment

Papers in ⓘ

Hepatology 20
- Hepatitis C virus research 20
Epidemiology 17
- Hepatitis B Virus Studies 15
- Liver Disease Diagnosis and Treatment 5

Co-authors: Oliver Lenz (10 shared papers)Kenneth Simmen (8 shared papers)Pierre Raboisson (12 shared papers)Gregory Fanning (6 shared papers)Thierry Verbinnen (4 shared papers)Herman de Kock (6 shared papers)Lotta Vrang (5 shared papers)Michael Edlund (5 shared papers)
Journals: Journal of Hepatology (12 papers)Antimicrobial Agents and Chemotherapy (3 papers)European Journal of Biochemistry (2 papers)Bioorganic & Medicinal Chemistry Letters (2 papers)Journal of Medicinal Chemistry (2 papers)
Partner nations: Sweden Belgium United States

In The Last Decade

Tse‐I Lin

25 papers receiving 660 citations

Peers

Countries citing papers authored by Tse‐I Lin

Since Specialization

Citations

This map shows the geographic impact of Tse‐I Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tse‐I Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tse‐I Lin more than expected).

Fields of papers citing papers by Tse‐I Lin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tse‐I Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tse‐I Lin. The network helps show where Tse‐I Lin may publish in the future.

Co-authors

The 25 scholars most cited alongside Tse‐I Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Tse‐I Lin Line = papers co-authored together Tse‐I Lin links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	In Vitro Resistance Profile of the Hepatitis C Virus NS3/4A Protease Inhibitor TMC435 Antimicrobial Agents and Chemotherapy ·Oliver Lenz, Thierry Verbinnen, Tse‐I Lin, Leen Vijgen, Maxwell D. Cummings, Jimmy Lindberg, Jan Martin Berke, Pascale Dehertogh, Els Fransen, Annick Scholliers, Katrien Vermeiren, Tania Ivens, Pierre Raboisson, Michael Edlund, Susan Storm, Lotta Vrang, Herman de Kock, Gregory Fanning, Kenneth Simmen	2010	178
2	In Vitro Activity and Preclinical Profile of TMC435350, a Potent Hepatitis C Virus Protease Inhibitor Antimicrobial Agents and Chemotherapy ·Tse‐I Lin, Oliver Lenz, Gregory Fanning, Thierry Verbinnen, Frédéric Delouvroy, Annick Scholliers, Katrien Vermeiren, Åsa Rosenquist, Michael Edlund, Bertil Samuelsson, Lotta Vrang, Herman de Kock, Piet Wigerinck, Pierre Raboisson, Kenneth Simmen	2009	142
3	Induced‐Fit Binding of the Macrocyclic Noncovalent Inhibitor TMC435 to its HCV NS3/NS4A Protease Target Angewandte Chemie International Edition ·Maxwell D. Cummings, Jimmy Lindberg, Tse‐I Lin, Herman de Kock, Oliver Lenz, Elisabet Lilja, Sara Felländer, Vera Baraznenok, Susanne Nyström, Magnus Nilsson, Lotta Vrang, Michael Edlund, Åsa Rosenquist, Bertil Samuelsson, Pierre Raboisson, Kenneth Simmen	2010	71
4	Tracking the Evolution of MultipleIn VitroHepatitis C Virus Replicon Variants under Protease Inhibitor Selection Pressure by 454 Deep Sequencing Journal of Virology ·Thierry Verbinnen, Herwig Van Marck, Ina Vandenbroucke, Leen Vijgen, Marijke Claes, Tse‐I Lin, Kenneth Simmen, Johan Neyts, Gregory Fanning, Oliver Lenz	2010	58
5	Antiviral Suppression vs Restoration of RIG-I Signaling by Hepatitis C Protease and Polymerase Inhibitors Gastroenterology ·Yuqiong Liang, Hisashi Ishida, Oliver Lenz, Tse‐I Lin, Origène Nyanguile, Kenny Simmen, Richard B. Pyles, Nigel Bourne, MinKyung Yi, Kui Li, Stanley M. Lemon	2008	39
6	Nucleotide Prodrugs of 2′-Deoxy-2′-spirooxetane Ribonucleosides as Novel Inhibitors of the HCV NS5B Polymerase Journal of Medicinal Chemistry ·Tim H. M. Jonckers, Koen Vandyck, Leen A. M. Vandekerckhove, Lili Hu, Abdellah Tahri, Steven Van Hoof, Tse‐I Lin, Leen Vijgen, Jan Martin Berke, Sophie Lachau‐Durand, Bart Stoops, Laurent Leclercq, Gregory Fanning, Bertil Samuelsson, Magnus Nilsson, Åsa Rosenquist, Kenny Simmen, Pierre Raboisson	2013	33
7	Regulation of gene transcription by thyroid hormone receptor β agonists in clinical development for the treatment of non-alcoholic steatohepatitis (NASH) PLoS ONE ·Xuan G. Luong, Sarah Stevens, Andreas Jekle, Tse‐I Lin, Kusum Gupta, Dinah Misner, Sushmita Chanda, Sucheta Mukherjee, Caroline Williams, Antitsa Stoycheva, Lawrence M. Blatt, Leonid N. Beigelman, Julian Symons, Pierre Raboisson, David C. McGowan, Koen Vandyck, Jerome Deval	2020	31
8	Discovery of novel potent and selective dipeptide hepatitis C virus NS3/4A serine protease inhibitors Bioorganic & Medicinal Chemistry Letters ·Pierre Raboisson, Tse‐I Lin, Herman de Kock, Sandrine Vendeville, Wim Van de Vreken, David C. McGowan, Abdellah Tahri, Lili Hu, Oliver Lenz, Frédéric Delouvroy, Dominique Surleraux, Piet Wigerinck, Magnus Nilsson, Åsa Rosenquist, Bertil Samuelsson, Kenneth Simmen	2008	18
9	Discovery of 1-((2R,4aR,6R,7R,7aR)-2-Isopropoxy-2-oxidodihydro-4H,6H-spiro[furo[3,2-d][1,3,2]dioxaphosphinine-7,2′-oxetan]-6-yl)pyrimidine-2,4(1H,3H)-dione (JNJ-54257099), a 3′-5′-Cyclic Phosphate Ester Prodrug of 2′-Deoxy-2′-Spirooxetane Uridine Triphosphate Useful for HCV Inhibition Journal of Medicinal Chemistry ·Tim H. M. Jonckers, Abdellah Tahri, Leen Vijgen, Jan Martin Berke, Sophie Lachau‐Durand, Bart Stoops, Jan Snoeys, Laurent Leclercq, Lotke Tambuyzer, Tse‐I Lin, Kenny Simmen, Pierre Raboisson	2016	18
10	Evaluation of the anti-hepatitis C virus effect of novel potent, selective, and orally bioavailable JNK and VEGFR kinase inhibitors Bioorganic & Medicinal Chemistry Letters ·Pierre Raboisson, Oliver Lenz, Tse‐I Lin, Dominique Surleraux, Sarvajit Chakravarty, Annick Scholliers, Katrien Vermeiren, Frédéric Delouvroy, Thierry Verbinnen, Kenneth Simmen	2007	11
11	Analysis of the Iron‐Sulfur Clusters Within the Complex I (NADH: Ubiquinone Oxidoreductase) Isolated from Potato Tuber Mitochondria European Journal of Biochemistry ·Tse‐I Lin, Vladimir D. Sled, Tomo̧ko Ohnishi, Axel Brennicke, Lutz Grohmann	1995	11
12	JNJ-64794964 (AL-034/TQ-A3334), a TLR7 agonist, induces sustained anti-HBV activity in AAV/HBV mice via non-cytolytic mechanisms Antiviral Research ·Florence Herschke, Chris Li, Ren Zhu, Qinglin Han, Qun Wu, Qing Lu, Erio Barale-Thomas, Sandra De Jonghe, Tse‐I Lin, An De Creus	2021	10
13	Analysis of the Iron-Sulfur Clusters Within the Complex I (NADH: Ubiquinone Oxidoreductase) Isolated from Potato Tuber Mitochondria European Journal of Biochemistry ·Tse‐I Lin, Vladimir D. Sled, Tomo̧ko Ohnishi, Axel Brennicke, Lutz Grohmann	1995	9
14	Development of a high-content screening assay to identify compounds interfering with the formation of the hepatitis C virus replication complex Journal of Virological Methods ·Jan Martin Berke, Denis Fenistein, Frederik Pauwels, Rob Bobbaers, Oliver Lenz, Tse‐I Lin, Eberhard Krausz, Gregory Fanning	2010	8
15	Safety, pharmacokinetics, and antiviral activity of the class II capsid assembly modulator ALG-000184 in subjects with chronic hepatitis B Journal of Hepatology ·Man‐Fung Yuen, Kosh Agarwal, Edward Gane, Alina Jucov, Christian Schwabe, Junqi Niu, Jinlin Hou, Kha Le, Benedetta Massetto, Christopher Westland, Qingling Zhang, Felix Lai, Meenakshi Venkatraman, Lawrence M. Blatt, Tse‐I Lin, Sushmita Chanda, Matt McClure, J. R. Fry	2022	8
16	Antiviral Activity and Mode of Action of TMC647078, a Novel Nucleoside Inhibitor of the Hepatitis C Virus NS5B Polymerase Antimicrobial Agents and Chemotherapy ·Jan Martin Berke, Leen Vijgen, Sophie Lachau‐Durand, Megan H. Powdrill, Svea Rawe, Elena Sjuvarsson, Staffan Eriksson, Matthias Götte, Els Fransen, Pascale Dehertogh, Christel Van den Eynde, Laurent Leclercq, Tim H. M. Jonckers, Pierre Raboisson, Magnus Nilsson, Bertil Samuelsson, Åsa Rosenquist, Gregory Fanning, Tse‐I Lin	2011	6
17	ALG-000184, a prodrug of capsid assembly modulator ALG-001075, demonstrates best-in-class preclinical characteristics for the treatment of chronic hepatitis B Journal of Hepatology ·Qingling Zhang, Sandrine Vendeville, V. N. Serebryany, Michael J. Welch, Jyanwei Liu, Caroline Williams, Yannick Debing, Andreas Jekle, Sarah Stevens, Jérôme Deval, Tse‐I Lin, Dinah Misner, Sushmita Chanda, Raymond F. Schinazi, Pierre Raboisson, Julian Symons, Lawrence M. Blatt, Leonid Beigelman, David J. Smith	2020	4
18	Safety, pharmacokinetics, and antiviral activity of single ascending doses of ALG-125755, a GalNAc-conjugated small interfering RNA, in subjects with chronic hepatitis B Journal of Hepatology ·Alina Jucov, Edward Gane, Megan Fitzgerald, Kha Le, Stanley Wang, Lynne Ammar, Chris Burnett, Alexei Haceatrean, Kusum Gupta, D. E. R. Clark, Meenakshi Venkatraman, Leonid Beigelman, Lawrence M. Blatt, Tse‐I Lin, Sushmita Chanda, Matthew W. McClure, John Fry	2023	4
19	Induced‐Fit Binding of the Macrocyclic Noncovalent Inhibitor TMC435 to its HCV NS3/NS4A Protease Target Angewandte Chemie ·Maxwell D. Cummings, Jimmy Lindberg, Tse‐I Lin, Herman de Kock, Oliver Lenz, Elisabet Lilja, Sara Felländer, Vera Baraznenok, Susanne Nyström, Magnus Nilsson, Lotta Vrang, Michael Edlund, Åsa Rosenquist, Bertil Samuelsson, Pierre Raboisson, Kenneth Simmen	2010	4
20	Pharmacodynamic durability of ALG-125755, a GalNAc-conjugated siRNA, correlated with total and RNA induced complex (RISC) bound siRNA in mouse liver Journal of Hepatology ·Kusum Gupta, Megan Fitzgerald, Jin Tae Hong, C. Cheng Kao, Cheng Liu, Kha Le, Sucheta Mukherjee, Dinah Misner, Meenakshi Venkatraman, Matt McClure, Sushmita Chanda, J. R. Fry, David B. Smith, Julian Symons, Lawrence M. Blatt, Leonid Beigelman, Tse‐I Lin	2023	1

About Tse‐I Lin

Tse‐I Lin is a scholar working on Hepatology, Epidemiology, Virology, Infectious Diseases and Radiology, Nuclear Medicine and Imaging, having authored 30 papers that have together received 670 indexed citations. Recurring topics across this work include Hepatitis C virus research (20 papers), Hepatitis B Virus Studies (15 papers), Monoclonal and Polyclonal Antibodies Research (6 papers), Liver Disease Diagnosis and Treatment (5 papers), HIV/AIDS drug development and treatment (5 papers), Biochemical and Molecular Research (4 papers), HIV Research and Treatment (2 papers) and Cassava research and cyanide (2 papers). The work is most often cited by research in Hepatology (480 citations), Infectious Diseases (276 citations), Epidemiology (377 citations), Virology (24 citations) and Rheumatology (52 citations). Tse‐I Lin has collaborated with scholars based in Sweden, Belgium and United States. Frequent co-authors include Oliver Lenz, Kenneth Simmen, Pierre Raboisson, Gregory Fanning, Thierry Verbinnen, Herman de Kock, Lotta Vrang, Michael Edlund, Annick Scholliers and Katrien Vermeiren. Their work appears in journals such as Journal of Hepatology, Antimicrobial Agents and Chemotherapy, European Journal of Biochemistry, Bioorganic & Medicinal Chemistry Letters and Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact